Nautilus Biotechnology shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Nautilus Biotechnology (NAUT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Nautilus Biotechnology
Tip: Access up to 7 years of quarterly data
All positions including Nautilus Biotechnology held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nautilus Biotechnology by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $100k | 118k | 0.84 |
| 2025-03-31 | $148k | 172k | 0.86 |
| 2024-12-31 | $329k | 196k | 1.68 |
| 2024-09-30 | $463k | 162k | 2.85 |
| 2024-06-30 | $194k | 83k | 2.34 |
| 2024-03-31 | $185k | 63k | 2.94 |
| 2023-12-31 | $200k | 67k | 2.99 |
| 2023-09-30 | $255k | 81k | 3.16 |
| 2023-06-30 | $368k | 95k | 3.87 |
| 2023-03-31 | $254k | 92k | 2.77 |
| 2022-12-31 | $128k | 71k | 1.80 |
| 2022-06-30 | $209k | 78k | 2.69 |
| 2022-03-31 | $406k | 94k | 4.34 |
| 2021-12-31 | $299k | 58k | 5.18 |
| 2021-09-30 | $64k | 10k | 6.14 |